August 10, 2017 - By Michael Collier


SANUWAVE HEALTH INCORPORATED (OTCMKTS:SNWV)’s shares fetched interest from OTC traders lately as its stock price moved $-0.007, reaching the $0.17 level after last close. Companies are ranked as per their market caps, divided into mid-cap, small-cap and large-cap segments. SANUWAVE HEALTH INCORPORATED (OTCMKTS:SNWV)’s market capitalization is $13.35 million.

Large-cap firms have a market cap of over $10 billion. These large firms have usually been in industry for a long time, and are major contributors in well-established segments. Investors in large-cap firms don’t necessarily bank hefty returns in short-time, instead they are rewarded with an increase in share value in the long run. Mid-cap firms have a market capitalization of $2 billion-$10 billion. Mid-cap firms are usually established firms operating in an industry that is projected to experience quick growth. Mid-cap firms are usually in the mid-stage of expansion. They carry increased risk than large-cap firms as they are not as established as large cap firms, though their growth prospects remain an attraction to shareholders.

Small-cap firms have a market capitalization of $300 million-$2 billion. These smaller firms are usually newer or possibly service a new industry or niche market. Generally considered to be at increased risk than large or mid-cap in part due to its size, age and the markets they serve. Small-cap firms typically have fewer resources and are more responsive to the ebb-and-flow of stock markets.

Are Shares of SANUWAVE HEALTH INCORPORATED All Set to Breakout to Full Potential? Enrol to Our Newsletter and Know the Inside Scoop!

SANUWAVE HEALTH INCORPORATED’s shares price has recorded $-71.27 month over month. Its short interest is recorded at 7,900 with as many as 0 days to close the position, against 27,500 in preceding month.

Over-the-counter stocks do not trade on major stock exchanges including the New York Stock Exchange (NYSE). These stocks are typically bought online via discount broker; they are not listed on a major exchange. OTC stocks are stated to be a riskier investment compared to other securities as they have been de-listed from a major exchange, or else do not meet the requirements for any of the reputed exchanges.

Ask and bid prices can be discovered on the OTC Bulletin Board and/or the “Pink Sheets”. Ask prices are simply the amount that the stockholder wants to receive. Bid prices, on the other hand, are the offered price of investors. OTC sellers can accept, refuse or suggest a new ask price. Another concern related to OTC stocks is that it is difficult to research on these stocks, as not enough statistical data is published. These companies are classically smaller in size or have witnessed some problems or issues. Cautious investors will require to research utilizing valid reference tools, like the OTC Research Corporation to know projections, operational performance, and expert opinions on the reliability and stability of OTC stocks and the firms that are behind them. These stocks can be bought online, but care and caution should be exercised.

Many stockbrokers who offer OTC stocks trail the pricing and operating report with less diligence compared to they do for securities listed on big stock exchanges. OTC stocks are stated as “thinly traded” securities following the sheer lack of volume compared to the other major stock exchanges. However, they can be bought online.

Get Breaking Alerts by Registering to our Newsletter! Hit on the Bar Below and Study About Securities that are Primed to Record a Run!

Due to lack of data regarding OTC stocks, care and caution should be taken before buying these securities. Only stockbrokers that own are informed about OTC stocks should be referred to, as they are aware with the differences between the major listed stocks and OTC stocks. Investors must assess the firms behind the OTC stock and know about their fundamental performance and if they have addressed any problems. Shareholders should check the important financial factors, specifically their capital, earnings per share, recent sales, book value and cash flow. Any newcomers to OTC marketplace should practice trading stocks first, due to the unpredictable and volatile nature of the stock market. A number of wired virtual trading programs let you to trade futures, options and stocks without any real financial risk.

Disclaimer: Nothing contained in this publication is intended to constitute legal, tax, securities, or investment advice, nor an opinion regarding the appropriateness of any investment, nor a solicitation of any type. The general information contained in this publication should not be acted upon without obtaining specific legal, tax, and investment advice from a licensed professional.

More notable recent SANUWAVE Health, Inc. (OTCMKTS:SNWV) news were published by: Marketwatch.com which released: “SANUWAVE Health Announces Extension of HealthTronics Promissory Notes” on August 03, 2017, also Globenewswire.com with their article: “SANUWAVE Health Achieves High End of Revenue Guidance for Q4 2016” published on January 26, 2017, Globenewswire.com published: “SANUWAVE Health Submits de novo Petition for FDA Review and Classification of …” on August 11, 2016. More interesting news about SANUWAVE Health, Inc. (OTCMKTS:SNWV) were released by: Orthospinenews.com and their article: “Sanuwave Health, Inc. Launches “Shock This” Blog” published on February 23, 2017 as well as Globenewswire.com‘s news article titled: “SANUWAVE Health Reports Record Year to Date Order Book for orthoPACE and …” with publication date: August 30, 2016.

SANUWAVE Health, Inc. is an acoustic pressure shock wave technology firm using a system of noninvasive, high-energy, acoustic pressure shock waves for indications, such as regenerative medicine and other applications. The company has market cap of $13.35 million. The Firm is focused on regenerative medicine utilizing noninvasive , acoustic pressure shock waves to produce a biological response resulting in the body healing itself through the repair and regeneration of skin, musculoskeletal tissue and vascular structures. It currently has negative earnings. The Company’s lead regenerative product in the United States is the dermaPACE device, used for treating diabetic foot ulcers.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.